Jennison Associates LLC 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-09 10:47 am Unchanged |
2025-05-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Jennison Associates LLC | 0 0.000% |
0 (Unchanged) |
Filing |
| 2025-06-04 4:30 pm Sale |
2025-04-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Jennison Associates LLC | 0 0.000% |
-6,993,422 (Position Closed) |
Filing |
| 2024-11-04 11:20 am Purchase |
2024-10-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Jennison Associates LLC | 6,993,422 10.400% |
6,993,422 (New Position) |
Filing |